started · updated
Alzheimer's disease: New diagnostic tools and therapies emerge
On World Alzheimer's Day, global health organizations and medical professionals are highlighting a shift toward a new era in dementia care, characterized by advancements in early diagnosis and the emergence of disease-modifying therapies. Research indicates that brain changes, such as cortical thickness variations, can be detected via MRI up to seven years before amyloid buildup is visible on PET scans.
In Spain, the healthcare system in Andalucía is progressively integrating blood biomarker analysis to improve early detection. Meanwhile, hospitals like Sanitas La Moraleja have begun administering anti-amyloid therapies, including donanemab and lecanemab, which can reduce the risk of clinical progression by 30-50%. Experts warn that early intervention is critical, as approximately 35-40% of cases remain undiagnosed.
In Poland, epidemiological data suggests roughly 618,000 people suffer from various forms of dementia, though formal diagnosis rates remain low. Globally, Alzheimer’s Disease International reports that while 158 potential treatments are currently in 192 clinical trials, a significant shortage of study participants poses a risk to research momentum. The number of people living with dementia is projected to rise from 60 million today to over 139 million by 2050.
Entities
Alzheimer Europe · Alzheimer's Association · Alzheimer's Disease International · Alzheimer’s Disease International · Andalucía · Andalusia · Confederación Española de Alzheimer y otras Demencias · Hospital Quirónsalud Córdoba · Hospital Universitario Sanitas La Moraleja · Junta de Andalucía · Murcia region · Poland
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] There are currently 158 potential treatments being evaluated in 192 clinical trials worldwide. www.demensforbundet.se
- [○ 1 SOURCE] Approximately 55,000 participants are needed for ongoing clinical trials, requiring roughly 350,000 interested applicants due to selection processes. www.demensforbundet.se
- [● 2 SOURCES] In 2025, approximately 18,000 people over age 65 in Andalucía were diagnosed with some form of dementia, including 12,000 with Alzheimer’s. diariocosta.com · www.lanocion.es
- [● 2 SOURCES] Data published in early 2026 indicates approximately 618,000 people in Poland suffer from various forms of dementia. zdrowie.co.pl · www.kierunekfarmacja.pl
- [○ 1 SOURCE] The hospital has begun administering donanemab and will soon start lecanemab, anti-amyloid therapies that slow Alzheimer’s progression in early stages. blog.segurostv.es
- [○ 1 SOURCE] By 2050, the number of people affected by Alzheimer’s in Spain could reach 3.6 million, triple the current figure of approximately 1.2 million. www.montilladigital.com
- [● 2 SOURCES] Andalucía is progressively incorporating blood biomarker analysis to improve early Alzheimer’s diagnosis in specialized care. diariocosta.com · www.lanocion.es